Clover Health Investments (NASDAQ:CLOV) is scheduled to issue its quarterly earnings data before the market opens on Monday, May 17th. Analysts expect the company to announce earnings of ($0.12) per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.
CLOV stock opened at $7.47 on Friday. Clover Health Investments has a twelve month low of $6.31 and a twelve month high of $17.45. The stock has a 50-day simple moving average of $8.37 and a two-hundred day simple moving average of $10.77.
CLOV has been the subject of a number of recent analyst reports. Citigroup reduced their target price on Clover Health Investments from $19.00 to $13.00 in a report on Wednesday, March 3rd. JPMorgan Chase & Co. initiated coverage on Clover Health Investments in a report on Monday, February 1st. They set a “neutral” rating and a $15.00 target price for the company. Credit Suisse Group began coverage on Clover Health Investments in a report on Monday, March 15th. They set a “neutral” rating and a $10.00 target price for the company. Finally, Zacks Investment Research raised Clover Health Investments from a “sell” rating to a “hold” rating in a report on Tuesday, May 4th.
Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2012 and is headquartered in Franklin, Tennessee.
Featured Article: How to calculate the intrinsic value of a stock
Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.